阿扎核苷治疗何时可治愈：老年骨髓增生异常综合征/急性髓系白血病患者同种异体移植前的非强化桥接策略 - Suppr

Suppr

超能文献

When azanucleoside treatment can be curative: nonintensive bridging strategy before allografting in older patients with myelodysplastic syndrome/acute myeloid leukemia.

作者信息

Lübbert Michael, Bertz Hartmut, Müller Michael Josef, Finke Jürgen

出版信息

J Clin Oncol. 2013 Feb 20;31(6):822-3. doi: 10.1200/JCO.2012.46.4222. Epub 2012 Nov 5.

DOI:10.1200/JCO.2012.46.4222

PMID:23129745

Abstract

摘要

相似文献

When azanucleoside treatment can be curative: nonintensive bridging strategy before allografting in older patients with myelodysplastic syndrome/acute myeloid leukemia.阿扎核苷治疗何时可治愈：老年骨髓增生异常综合征/急性髓系白血病患者同种异体移植前的非强化桥接策略

J Clin Oncol. 2013 Feb 20;31(6):822-3. doi: 10.1200/JCO.2012.46.4222. Epub 2012 Nov 5.

What is better for older patients with acute myeloid leukemia?对于老年急性髓系白血病患者，什么治疗方法更好？

J Clin Oncol. 2013 Feb 20;31(6):820-1. doi: 10.1200/JCO.2012.45.2219. Epub 2012 Nov 5.

The euphoria of hypomethylating agents in MDS and AML: is it justified?低甲基化药物在 MDS 和 AML 中的兴奋：这合理吗？

Best Pract Res Clin Haematol. 2013 Sep;26(3):275-8. doi: 10.1016/j.beha.2013.10.001. Epub 2013 Oct 15.

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.阿扎胞苷改善了伴有骨髓增生异常相关改变的老年急性髓系白血病患者的临床结局，优于常规治疗方案。

BMC Cancer. 2017 Dec 14;17(1):852. doi: 10.1186/s12885-017-3803-6.

Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.对于由骨髓增生异常综合征继发的急性髓系白血病患者，在接受标准诱导化疗时，既往使用去甲基化药物对临床结局无影响。

Int J Hematol. 2016 Apr;103(4):409-15. doi: 10.1007/s12185-016-1935-0. Epub 2016 Jan 18.

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.阿扎胞苷对急性髓系白血病异基因干细胞移植后复发患者的临床活性。

Haematologica. 2016 Jul;101(7):879-83. doi: 10.3324/haematol.2015.140996. Epub 2016 Apr 14.

Hypomethylating agents and chemotherapy in MDS.低甲基化药物和 MDS 中的化疗。

Best Pract Res Clin Haematol. 2013 Dec;26(4):411-9. doi: 10.1016/j.beha.2013.09.010. Epub 2013 Oct 7.

[Curative Effect of Decitabine Combined with IAG Regimen for Senile Patients with Myelodysplastic Syndrome (MDS) Transformed Acute Myeloid Leukemia].地西他滨联合IAG方案治疗老年骨髓增生异常综合征（MDS）转化的急性髓系白血病的疗效

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1641-1646. doi: 10.7534/j.issn.1009-2137.2017.06.011.

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.阿扎胞苷联合强化诱导化疗治疗老年急性髓系白血病：白血病研究联盟 AML-AZA 试验。

Leukemia. 2016 Mar;30(3):555-61. doi: 10.1038/leu.2015.306. Epub 2015 Nov 2.

Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting.在日常生活环境中，阿扎胞苷治疗失败后，继发于骨髓增生异常综合征和慢性粒单核细胞白血病的急性髓系白血病预后不佳。

Acta Haematol. 2015;133(1):64-6. doi: 10.1159/000363643. Epub 2014 Aug 14.

引用本文的文献

Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?急性髓系白血病诱导缓解的剂量强度：什么是合适的剂量强度，何时应用，以及针对哪些患者？

Haematologica. 2021 Oct 1;106(10):2544-2554. doi: 10.3324/haematol.2020.269134.

Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation.接受异基因造血细胞移植治疗的治疗相关骨髓增生异常综合征和急性髓系白血病患者的长期随访

Bone Marrow Transplant. 2016 Jun;51(6):771-7. doi: 10.1038/bmt.2015.338. Epub 2016 Jan 11.

Clinical Results of Hypomethylating Agents in AML Treatment.去甲基化药物治疗急性髓系白血病的临床结果

J Clin Med. 2014 Dec 25;4(1):1-17. doi: 10.3390/jcm4010001.

Decitabine in the treatment of acute myeloid leukemia in elderly patients.地西他滨治疗老年急性髓系白血病

Cancer Manag Res. 2014 Feb 3;6:53-61. doi: 10.2147/CMAR.S40600. eCollection 2014.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验